Trial Profile
Phase I/II study of docetaxel, CDDP and 5-FU therapy in patients with unresectable or recurrent esophageal cancer.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Cisplatin; Fluorouracil
- Indications Oesophageal cancer
- Focus Adverse reactions; Therapeutic Use
- 11 Jul 2013 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 26 Mar 2013 Status changed from suspended to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 02 Mar 2011 Status changed from recruiting to suspended as reported by University Hospital Medical Information Network - Japan.